Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus

Clinical and Experimental Dermatology

Volumn 37, Issue 4, 2012, Pages 327-334

  Ezra, N ^a   Jorizzo, J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; MEPACRINE;

CIGARETTE SMOKING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; LONG TERM CARE; MONOTHERAPY; PRIORITY JOURNAL; REMISSION; REVIEW; SKIN LUPUS ERYTHEMATOSUS; TREATMENT REFUSAL; TREATMENT RESPONSE;

ANTIMALARIALS; DERMATOLOGIC AGENTS; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, CUTANEOUS; MEDICATION ADHERENCE; SMOKING;

EID: 84861121070     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04266.x     Document Type: Review

References (80)

1. Smith CD, Cyr M,. The history of lupus erythematosus. From Hippocrates to Osler. Rheum Dis Clin North Am 1988; 14: 1-14.
2. Bolognia J, Jorizzo J, Rapini R,. Dermatology, 2nd edn. Spain: Mosby Elsevier, 2008: 527-3.
3. Dubois EL,. Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum 1978; 8: 33-51. (Pubitemid 9021790)
4. Sokol RJ, Lichtenstein PK, Farrell MK,. Quinacrine hydrochloride-induced yellow discoloration of the skin in children. Pediatrics 1982; 69: 232-3. (Pubitemid 12222210)
5. Rovelstad RA, Stauffer MH, Mason HL, Steinhilber RM,. The simulation of jaundice by action of quinacrine (atabrine). Gastroenterology 1957; 33: 937-47.
6. Michaelides M, Stover NB, Francis PJ, Weleber RG,. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol 2011; 129: 30-9.
7. Rothfield NF, Evans AS, Niederman JC,. Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann Rheum Dis 1973; 32: 238-46.
8. Rothfield N, Sontheimer RD, Bernstein M,. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 2006; 24: 348-62. (Pubitemid 44332871)
9. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113-24. (Pubitemid 23097765)
10. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology. J Am Acad Dermatol 1996; 34: 830-6. (Pubitemid 26137212)
11. Geraminejad P, Stone MS, Sontheimer RD,. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus. Lupus 2004; 13: 473-7. (Pubitemid 38931781)
12. Magro CM, Crowson AN, Schapiro BL,. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 1998; 25: 72-8. (Pubitemid 28073644)
13. Sontheimer RD, Maddison PJ, Reichlin M, et al. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982; 97: 664-71. (Pubitemid 13251635)
14. Mond CB, Peterson MG, Rothfield NF,. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 1989; 32: 202-4. (Pubitemid 19056408)
15. Rothfield NF,. The diagnostic features of SLE. Hosp Pract (Off Eds) 1989; 24: 37-46. (Pubitemid 19044368)
16. Sontheimer RD,. Clinical manifestations of cutaneous lupus erythematosus. In: Dubois' Lupus Erythematosus (, Wallace DJ, Hahn BH, eds). Philadelphia, PA: Lea & Febiger, 1993: 285-301.
17. Rahman P, Gladman DD, Urowitz MB,. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 1998; 25: 1716-19. (Pubitemid 28439264)
18. Tzekov R,. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol 2005; 110: 111-20. (Pubitemid 43055086)
19. Lloyd LA, Hiltz JW,. Ocular complications of chloroquine therapy. Can Med Assoc J 1965; 92: 508-13.
20. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004; 50: 849-57. (Pubitemid 38326185)
21. George J, Levy Y, Shoenfeld Y,. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 1997; 45: 1-6. (Pubitemid 27013960)
22. Nagata C, Fujita S, Iwata H, et al. Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 1995; 34: 333-7.
23. Gallego H, Crutchfield CE III, Lewis EJ, Gallego HJ,. Report of an association between discoid lupus erythematosus and smoking. Cutis 1999; 63: 231-4.
24. Costenbader KH, Karlson EW,. Cigarette smoking and systemic lupus erythematosus: a smoking gun? Autoimmunity 2005; 38: 541-7. (Pubitemid 43101788)
25. Koskenmies S, Jarvinen TM, Onkamo P, et al. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus 2008; 17: 337-47. (Pubitemid 351655803)
26. Ghaussy NO, Sibbitt W Jr, Bankhurst AD, Qualls CR,. Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 2003; 30: 1215-21. (Pubitemid 36666343)
27. Miot HA, Bartoli Miot LD, Haddad GR,. Association between discoid lupus erythematosus and cigarette smoking. Dermatology 2005; 211: 118-22. (Pubitemid 41160246)
28. Boeckler P, Milea M, Meyer A, et al. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency. Br J Dermatol 2005; 152: 265-70. (Pubitemid 40343596)
29. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. Plos Med 2009; 6: e1000058.
30. Center for Disease Control (CDC). Smoking-attributable mortality, years of potential lifelost and productivity losses-United States. 2000-2004. MMWR Morb Mortal Wkly Rep 2008; 57: 1226-8.
31. Mamudu HM, Hammond R, Glantz S,. Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control. Soc Sci Med 2008; 67: 1690-9.
32. Ghaussy NO, Sibbitt WL Jr, Qualls CR,. Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol 2001; 28: 2449-53. (Pubitemid 33031975)
33. Jewell ML, Mccauliffe DP,. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 2000; 42: 983-7. (Pubitemid 30368665)
34. Kreuter A, Gaifullina R, Tigges C, et al. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking. Arch Dermatol 2009; 145: 244-8.
35. Hugel R, Schwarz T, Glaser R,. Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus. Br J Dermatol 2007; 157: 1081-3. (Pubitemid 47583525)
36. Callen JP,. Management of antimalarial-refractory cutaneous lupus erythematosus. Lupus 1997; 6: 203-8. (Pubitemid 27102048)
37. Duna GF, Cash JM,. Treatment of refractory cutaneous lupus erythematosus. Rheum Dis Clin North Am 1995; 21: 99-115.
38. Feldmann R, Salomon D, Saurat JH,. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 1994; 189: 425-7. (Pubitemid 24358003)
39. Lipsker D, Piette JC, Cacoub P, et al. Chloroquine-quinacrine association in resistant cutaneous lupus. Dermatology 1995; 190: 257-8.
40. Cavazzana I, Sala R, Bazzani C, et al. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. Lupus 2009; 18: 735-9.
41. Wanwimolruk S, Wong SM, Coville PF, et al. Cigarette smoking enhances the elimination of quinine. Br J Clin Pharmacol 1993; 36: 610-14. (Pubitemid 24001727)
42. Schein JR,. Cigarette smoking and clinically significant drug interactions. Ann Pharmacother 1995; 29: 1139-48.
43. Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 3284-90. (Pubitemid 44622099)
44. Costedoat-Chalumeau N, Amoura Z, Hulot JS, et al. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus. Ann Rheum Dis 2007; 66: 821-4. (Pubitemid 46846706)
45. Leroux G, Costedoat-Chalumeau N, Hulot JS, et al. Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases. Ann Rheum Dis 2007; 66: 1547-8. (Pubitemid 350032673)
46. Fox R,. Anti-malarial drugs. possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus 1996; 5 (Suppl. 1): S4-10. (Pubitemid 26196734)
47. Korsch BM, Gozzi EK, Francis V,. Gaps in doctor-patient communication. 1. Doctor-patient interaction and patient satisfaction. Pediatrics 1968; 42: 855-71.
48. Polet H,. The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes. J Cell Physiol 1985; 122: 415-23. (Pubitemid 15127514)
49. Seltzer CC, Friedman GD, Siegelaub AB, Collen MF,. Smoking habits and pain tolerance. Arch Environ Health 1974; 29: 170-2.
50. Ferguson D,. Smoking, drinking and non-narcotic analgesic habits in an occupational group. Med J Aust 1973; 1: 1271-4.
51. Davis MS,. Variations in patients' compliance with doctors' advice: an empirical analysis of patterns o communication. Am J Public Health Nations Health 1968; 58: 274-88.
52. Dimatteo MR,. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200-9.
53. Jessor R, Turbin MS, Costa FM,. Protective factors in adolescent health behavior. J Pers Soc Psychol 1998; 75: 788-800.
54. Eiser JR, Sutton SR, Wober M,. Smoking, seat-belts, and beliefs about health. Addict Behav 1979; 4: 331-8. (Pubitemid 10160560)
55. Valois RF, Oeltmann JE, Waller J, Hussey JR,. Relationship between number of sexual intercourse partners and selected health risk behaviors among public high school adolescents. J Adolesc Health 1999; 25: 328-35. (Pubitemid 29495867)
56. Morabia A, Wynder EL,. Dietary habits of smokers, people who never smoked, and exsmokers. Am J Clin Nutr 1990; 52: 933-7.
57. Emmons KM, Marcus BH, Linnan L, et al. Mechanisms in multiple risk factor interventions: smoking, physical activity, and dietary fat intake among manufacturing workers. Working Well Research Group. Prev Med 1994; 23: 481-9. (Pubitemid 24280667)
58. Carlos RC, Fendrick AM, Patterson SK, Bernstein SJ,. Associations in breast and colon cancer screening behavior in women. Acad Radiol 2005; 12: 451-8.
59. Carlos RC, Fendrick AM, Abrahamse PH, et al. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. Womens Health Issues 2005; 15: 249-57. (Pubitemid 41735225)
60. Burkhalter JE, Springer CM, Chhabra R, et al. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005; 7: 511-22. (Pubitemid 41600909)
61. Miguez-Burbano MJ, Ashkin D, Rodriguez A, et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 2005; 9: 208-17. (Pubitemid 40827162)
62. Niaura R, Shadel WG, Morrow K, et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 2000; 31: 808-12. (Pubitemid 32295508)
63. Webb MS, Vanable PA, Carey MP, Blair DC,. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 2007; 30: 371-83. (Pubitemid 47206603)
64. Shah ND, Dunlay SM, Ting HH, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med 2009; 122: 961.e7-13.
65. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-7. (Pubitemid 44455166)
66. Aggarwal B, Mosca L,. Lifestyle and psychosocial risk factors predict non-adherence to medication. Ann Behav Med 2010; 40: 228-33.
67. Banning M,. A review of interventions used to improve adherence to medication in older people. Int J Nurs Stud 2009; 46: 1505-15.
68. Webb MS, Vanable PA, Carey MP, Blair DC,. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Educ Prev 2009; 21: 94-105.
69. Shuter J, Bernstein SL,. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res 2008; 10: 731-6. (Pubitemid 351566558)
70. Tsakonas E, Joseph L, Esdaile JM, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 1998; 7: 80-5. (Pubitemid 28107971)
71. Pons-Estel GJ, Alarcon GS, Gonzalez LA, et al. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken) 2010; 62: 393-400.
72. Kaiser R, Cleveland CM, Criswell LA,. Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis 2009; 68: 238-41.
73. Pryor WA, Stone K,. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993; 686: 12-27.
74. Pryor WA, Stone K, Zang LY, Bermudez E,. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol 1998; 11: 441-8. (Pubitemid 28242488)
75. Majka DS, Holers VM,. Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2006; 65: 561-3.
76. Placzek M, Kerkmann U, Bell S, et al. Tobacco smoke is phototoxic. Br J Dermatol 2004; 150: 991-3. (Pubitemid 38903534)
77. Bermudez EA, Rifai N, Buring JE, et al. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002; 89: 1117-19. (Pubitemid 34462860)
78. Kuhn A, Sonntag M, Sunderkotter C, et al. Upregulation of epidermal surface molecule expression in primary and ultraviolet-induced lesions of lupus erythematosus tumidus. Br J Dermatol 2002; 146: 801-9. (Pubitemid 34539189)
79. Seagrave J, Barr EB, March TH, Nikula KJ,. Effects of cigarette smoke exposure and cessation on inflammatory cells and matrix metalloproteinase activity in mice. Exp Lung Res 2004; 30: 1-15. (Pubitemid 38117522)
80. Metelitsa AI, Lauzon GJ,. Tobacco and the skin. Clin Dermatol 2010; 28: 384-90.